Cost-effectiveness of posaconazole versusfluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain

Peer Review reports

Original Submission
12 Sep 2011	Submitted	Original manuscript
14 Dec 2011	Reviewed	Reviewer Report - Michael Pfaller
16 Jan 2012	Reviewed	Reviewer Report - Dominique Sanglard
24 Feb 2012	Author responded	Author comments - Santiago Grau
Resubmission - Version 2
24 Feb 2012	Submitted	Manuscript version 2
Publishing
3 Apr 2012	Editorially accepted
3 Apr 2012	Article published	10.1186/1471-2334-12-83

Back to article page